References from Abstract No: 307 PREVAIL: A PHASE 3 TRIAL OF FELZARTAMAB IN ADULTS WITH IgA NEPHROPATHY. Local targets link to admitted publications; unresolved targets remain external evidence.
No reference evidence is available for this admitted work.
References for Abstract No: 307 PREVAIL: A PHASE 3 TRIAL OF FELZARTAMAB IN ADULTS WITH IgA NEPHROPATHY | ResearchHub - ResearchHub
